ソマトスタチン受容体2型の世界市場（～2026年）

• 英文タイトル：Global Somatostatin Receptor Type 2 Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY09862 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はソマトスタチン受容体2型のグローバル市場について調査・分析したレポートです。種類別（CRN-00808、酢酸ランレオチド、PRL-2903、その他）市場規模、用途別（ホルモン障害、腫瘍、代謝障害、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ソマトスタチン受容体2型の競争状況、市場シェア ・世界のソマトスタチン受容体2型市場：種類別市場規模 2015年-2020年（CRN-00808、酢酸ランレオチド、PRL-2903、その他） ・世界のソマトスタチン受容体2型市場：種類別市場規模予測 2021年-2026年（CRN-00808、酢酸ランレオチド、PRL-2903、その他） ・世界のソマトスタチン受容体2型市場：用途別市場規模 2015年-2020年（ホルモン障害、腫瘍、代謝障害、その他） ・世界のソマトスタチン受容体2型市場：用途別市場規模予測 2021年-2026年（ホルモン障害、腫瘍、代謝障害、その他） ・北米のソマトスタチン受容体2型市場分析：米国、カナダ ・ヨーロッパのソマトスタチン受容体2型市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのソマトスタチン受容体2型市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のソマトスタチン受容体2型市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのソマトスタチン受容体2型市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amryt Pharma plc、Crinetics Pharmaceuticals Inc、Daewoong Pharmaceutical Co Ltd、Ipsen SA、Progenics Pharmaceuticals Inc、Strongbridge Biopharma plc、Zucara Therapeutics Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Somatostatin Receptor Type 2 Market
The global Somatostatin Receptor Type 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Somatostatin Receptor Type 2 Scope and Market Size
Somatostatin Receptor Type 2 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Somatostatin Receptor Type 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Somatostatin Receptor Type 2 market is segmented into
CRN-00808
Lanreotide Acetate
PRL-2903
Others

Segment by Application, the Somatostatin Receptor Type 2 market is segmented into
Hormonal Disorder
Oncology
Metabolic Disorder
Others

Regional and Country-level Analysis
The Somatostatin Receptor Type 2 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Somatostatin Receptor Type 2 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Somatostatin Receptor Type 2 Market Share Analysis
Somatostatin Receptor Type 2 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Somatostatin Receptor Type 2 business, the date to enter into the Somatostatin Receptor Type 2 market, Somatostatin Receptor Type 2 product introduction, recent developments, etc.

The major vendors covered:
Amryt Pharma plc
Crinetics Pharmaceuticals Inc
Daewoong Pharmaceutical Co Ltd
Ipsen SA
Progenics Pharmaceuticals Inc
Strongbridge Biopharma plc
Zucara Therapeutics Inc
…

レポート目次

---

1 Study Coverage
1.1 Somatostatin Receptor Type 2 Product Introduction
1.2 Market Segments
1.3 Key Somatostatin Receptor Type 2 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Somatostatin Receptor Type 2 Market Size Growth Rate by Type
1.4.2 CRN-00808
1.4.3 Lanreotide Acetate
1.4.4 PRL-2903
1.4.5 Others
1.5 Market by Application
1.5.1 Global Somatostatin Receptor Type 2 Market Size Growth Rate by Application
1.5.2 Hormonal Disorder
1.5.3 Oncology
1.5.4 Metabolic Disorder
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Somatostatin Receptor Type 2 Market Size, Estimates and Forecasts
2.1.1 Global Somatostatin Receptor Type 2 Revenue 2015-2026
2.1.2 Global Somatostatin Receptor Type 2 Sales 2015-2026
2.2 Global Somatostatin Receptor Type 2, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Somatostatin Receptor Type 2 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Somatostatin Receptor Type 2 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Somatostatin Receptor Type 2 Competitor Landscape by Players
3.1 Somatostatin Receptor Type 2 Sales by Manufacturers
3.1.1 Somatostatin Receptor Type 2 Sales by Manufacturers (2015-2020)
3.1.2 Somatostatin Receptor Type 2 Sales Market Share by Manufacturers (2015-2020)
3.2 Somatostatin Receptor Type 2 Revenue by Manufacturers
3.2.1 Somatostatin Receptor Type 2 Revenue by Manufacturers (2015-2020)
3.2.2 Somatostatin Receptor Type 2 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Somatostatin Receptor Type 2 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Somatostatin Receptor Type 2 Revenue in 2019
3.2.5 Global Somatostatin Receptor Type 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Somatostatin Receptor Type 2 Price by Manufacturers
3.4 Somatostatin Receptor Type 2 Manufacturing Base Distribution, Product Types
3.4.1 Somatostatin Receptor Type 2 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Somatostatin Receptor Type 2 Product Type
3.4.3 Date of International Manufacturers Enter into Somatostatin Receptor Type 2 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Somatostatin Receptor Type 2 Market Size by Type (2015-2020)
4.1.1 Global Somatostatin Receptor Type 2 Sales by Type (2015-2020)
4.1.2 Global Somatostatin Receptor Type 2 Revenue by Type (2015-2020)
4.1.3 Somatostatin Receptor Type 2 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Somatostatin Receptor Type 2 Market Size Forecast by Type (2021-2026)
4.2.1 Global Somatostatin Receptor Type 2 Sales Forecast by Type (2021-2026)
4.2.2 Global Somatostatin Receptor Type 2 Revenue Forecast by Type (2021-2026)
4.2.3 Somatostatin Receptor Type 2 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Somatostatin Receptor Type 2 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Somatostatin Receptor Type 2 Market Size by Application (2015-2020)
5.1.1 Global Somatostatin Receptor Type 2 Sales by Application (2015-2020)
5.1.2 Global Somatostatin Receptor Type 2 Revenue by Application (2015-2020)
5.1.3 Somatostatin Receptor Type 2 Price by Application (2015-2020)
5.2 Somatostatin Receptor Type 2 Market Size Forecast by Application (2021-2026)
5.2.1 Global Somatostatin Receptor Type 2 Sales Forecast by Application (2021-2026)
5.2.2 Global Somatostatin Receptor Type 2 Revenue Forecast by Application (2021-2026)
5.2.3 Global Somatostatin Receptor Type 2 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Somatostatin Receptor Type 2 by Country
6.1.1 North America Somatostatin Receptor Type 2 Sales by Country
6.1.2 North America Somatostatin Receptor Type 2 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Somatostatin Receptor Type 2 Market Facts & Figures by Type
6.3 North America Somatostatin Receptor Type 2 Market Facts & Figures by Application

7 Europe
7.1 Europe Somatostatin Receptor Type 2 by Country
7.1.1 Europe Somatostatin Receptor Type 2 Sales by Country
7.1.2 Europe Somatostatin Receptor Type 2 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Somatostatin Receptor Type 2 Market Facts & Figures by Type
7.3 Europe Somatostatin Receptor Type 2 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Somatostatin Receptor Type 2 by Region
8.1.1 Asia Pacific Somatostatin Receptor Type 2 Sales by Region
8.1.2 Asia Pacific Somatostatin Receptor Type 2 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Somatostatin Receptor Type 2 Market Facts & Figures by Type
8.3 Asia Pacific Somatostatin Receptor Type 2 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Somatostatin Receptor Type 2 by Country
9.1.1 Latin America Somatostatin Receptor Type 2 Sales by Country
9.1.2 Latin America Somatostatin Receptor Type 2 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Somatostatin Receptor Type 2 Market Facts & Figures by Type
9.3 Central & South America Somatostatin Receptor Type 2 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Somatostatin Receptor Type 2 by Country
10.1.1 Middle East and Africa Somatostatin Receptor Type 2 Sales by Country
10.1.2 Middle East and Africa Somatostatin Receptor Type 2 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Somatostatin Receptor Type 2 Market Facts & Figures by Type
10.3 Middle East and Africa Somatostatin Receptor Type 2 Market Facts & Figures by Application

11 Company Profiles
11.1 Amryt Pharma plc
11.1.1 Amryt Pharma plc Corporation Information
11.1.2 Amryt Pharma plc Description and Business Overview
11.1.3 Amryt Pharma plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amryt Pharma plc Somatostatin Receptor Type 2 Products Offered
11.1.5 Amryt Pharma plc Related Developments
11.2 Crinetics Pharmaceuticals Inc
11.2.1 Crinetics Pharmaceuticals Inc Corporation Information
11.2.2 Crinetics Pharmaceuticals Inc Description and Business Overview
11.2.3 Crinetics Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Products Offered
11.2.5 Crinetics Pharmaceuticals Inc Related Developments
11.3 Daewoong Pharmaceutical Co Ltd
11.3.1 Daewoong Pharmaceutical Co Ltd Corporation Information
11.3.2 Daewoong Pharmaceutical Co Ltd Description and Business Overview
11.3.3 Daewoong Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Products Offered
11.3.5 Daewoong Pharmaceutical Co Ltd Related Developments
11.4 Ipsen SA
11.4.1 Ipsen SA Corporation Information
11.4.2 Ipsen SA Description and Business Overview
11.4.3 Ipsen SA Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ipsen SA Somatostatin Receptor Type 2 Products Offered
11.4.5 Ipsen SA Related Developments
11.5 Progenics Pharmaceuticals Inc
11.5.1 Progenics Pharmaceuticals Inc Corporation Information
11.5.2 Progenics Pharmaceuticals Inc Description and Business Overview
11.5.3 Progenics Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Products Offered
11.5.5 Progenics Pharmaceuticals Inc Related Developments
11.6 Strongbridge Biopharma plc
11.6.1 Strongbridge Biopharma plc Corporation Information
11.6.2 Strongbridge Biopharma plc Description and Business Overview
11.6.3 Strongbridge Biopharma plc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Products Offered
11.6.5 Strongbridge Biopharma plc Related Developments
11.7 Zucara Therapeutics Inc
11.7.1 Zucara Therapeutics Inc Corporation Information
11.7.2 Zucara Therapeutics Inc Description and Business Overview
11.7.3 Zucara Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Products Offered
11.7.5 Zucara Therapeutics Inc Related Developments
11.1 Amryt Pharma plc
11.1.1 Amryt Pharma plc Corporation Information
11.1.2 Amryt Pharma plc Description and Business Overview
11.1.3 Amryt Pharma plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amryt Pharma plc Somatostatin Receptor Type 2 Products Offered
11.1.5 Amryt Pharma plc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Somatostatin Receptor Type 2 Market Estimates and Projections by Region
12.1.1 Global Somatostatin Receptor Type 2 Sales Forecast by Regions 2021-2026
12.1.2 Global Somatostatin Receptor Type 2 Revenue Forecast by Regions 2021-2026
12.2 North America Somatostatin Receptor Type 2 Market Size Forecast (2021-2026)
12.2.1 North America: Somatostatin Receptor Type 2 Sales Forecast (2021-2026)
12.2.2 North America: Somatostatin Receptor Type 2 Revenue Forecast (2021-2026)
12.2.3 North America: Somatostatin Receptor Type 2 Market Size Forecast by Country (2021-2026)
12.3 Europe Somatostatin Receptor Type 2 Market Size Forecast (2021-2026)
12.3.1 Europe: Somatostatin Receptor Type 2 Sales Forecast (2021-2026)
12.3.2 Europe: Somatostatin Receptor Type 2 Revenue Forecast (2021-2026)
12.3.3 Europe: Somatostatin Receptor Type 2 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Somatostatin Receptor Type 2 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Somatostatin Receptor Type 2 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Somatostatin Receptor Type 2 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Somatostatin Receptor Type 2 Market Size Forecast by Region (2021-2026)
12.5 Latin America Somatostatin Receptor Type 2 Market Size Forecast (2021-2026)
12.5.1 Latin America: Somatostatin Receptor Type 2 Sales Forecast (2021-2026)
12.5.2 Latin America: Somatostatin Receptor Type 2 Revenue Forecast (2021-2026)
12.5.3 Latin America: Somatostatin Receptor Type 2 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Somatostatin Receptor Type 2 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Somatostatin Receptor Type 2 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Somatostatin Receptor Type 2 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Somatostatin Receptor Type 2 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Somatostatin Receptor Type 2 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Somatostatin Receptor Type 2 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Somatostatin Receptor Type 2 Market Segments
Table 2. Ranking of Global Top Somatostatin Receptor Type 2 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Somatostatin Receptor Type 2 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of CRN-00808
Table 5. Major Manufacturers of Lanreotide Acetate
Table 6. Major Manufacturers of PRL-2903
Table 7. Major Manufacturers of Others
Table 8. Global Somatostatin Receptor Type 2 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Somatostatin Receptor Type 2 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Somatostatin Receptor Type 2 Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Somatostatin Receptor Type 2 Sales Market Share by Regions (2015-2020)
Table 12. Global Somatostatin Receptor Type 2 Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Somatostatin Receptor Type 2 Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Somatostatin Receptor Type 2 Sales Share by Manufacturers (2015-2020)
Table 15. Global Somatostatin Receptor Type 2 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Somatostatin Receptor Type 2 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin Receptor Type 2 as of 2019)
Table 17. Somatostatin Receptor Type 2 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Somatostatin Receptor Type 2 Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Somatostatin Receptor Type 2 Price (2015-2020) (USD/Pcs)
Table 20. Somatostatin Receptor Type 2 Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Somatostatin Receptor Type 2 Product Type
Table 22. Date of International Manufacturers Enter into Somatostatin Receptor Type 2 Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Somatostatin Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 25. Global Somatostatin Receptor Type 2 Sales Share by Type (2015-2020)
Table 26. Global Somatostatin Receptor Type 2 Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Somatostatin Receptor Type 2 Revenue Share by Type (2015-2020)
Table 28. Somatostatin Receptor Type 2 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Somatostatin Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 30. Global Somatostatin Receptor Type 2 Sales Share by Application (2015-2020)
Table 31. North America Somatostatin Receptor Type 2 Sales by Country (2015-2020) (K Pcs)
Table 32. North America Somatostatin Receptor Type 2 Sales Market Share by Country (2015-2020)
Table 33. North America Somatostatin Receptor Type 2 Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Somatostatin Receptor Type 2 Revenue Market Share by Country (2015-2020)
Table 35. North America Somatostatin Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 36. North America Somatostatin Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 37. North America Somatostatin Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 38. North America Somatostatin Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 39. Europe Somatostatin Receptor Type 2 Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Somatostatin Receptor Type 2 Sales Market Share by Country (2015-2020)
Table 41. Europe Somatostatin Receptor Type 2 Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Somatostatin Receptor Type 2 Revenue Market Share by Country (2015-2020)
Table 43. Europe Somatostatin Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Somatostatin Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 45. Europe Somatostatin Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Somatostatin Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Somatostatin Receptor Type 2 Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Somatostatin Receptor Type 2 Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Somatostatin Receptor Type 2 Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Somatostatin Receptor Type 2 Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Somatostatin Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Somatostatin Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Somatostatin Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Somatostatin Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 55. Latin America Somatostatin Receptor Type 2 Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Somatostatin Receptor Type 2 Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Somatostatin Receptor Type 2 Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Somatostatin Receptor Type 2 Revenue Market Share by Country (2015-2020)
Table 59. Latin America Somatostatin Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Somatostatin Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 61. Latin America Somatostatin Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Somatostatin Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Somatostatin Receptor Type 2 Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Somatostatin Receptor Type 2 Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Somatostatin Receptor Type 2 Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Somatostatin Receptor Type 2 Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Somatostatin Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Somatostatin Receptor Type 2 Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Somatostatin Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Somatostatin Receptor Type 2 Sales Market Share by Application (2015-2020)
Table 71. Amryt Pharma plc Corporation Information
Table 72. Amryt Pharma plc Description and Major Businesses
Table 73. Amryt Pharma plc Somatostatin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Amryt Pharma plc Product
Table 75. Amryt Pharma plc Recent Development
Table 76. Crinetics Pharmaceuticals Inc Corporation Information
Table 77. Crinetics Pharmaceuticals Inc Description and Major Businesses
Table 78. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Crinetics Pharmaceuticals Inc Product
Table 80. Crinetics Pharmaceuticals Inc Recent Development
Table 81. Daewoong Pharmaceutical Co Ltd Corporation Information
Table 82. Daewoong Pharmaceutical Co Ltd Description and Major Businesses
Table 83. Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Daewoong Pharmaceutical Co Ltd Product
Table 85. Daewoong Pharmaceutical Co Ltd Recent Development
Table 86. Ipsen SA Corporation Information
Table 87. Ipsen SA Description and Major Businesses
Table 88. Ipsen SA Somatostatin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Ipsen SA Product
Table 90. Ipsen SA Recent Development
Table 91. Progenics Pharmaceuticals Inc Corporation Information
Table 92. Progenics Pharmaceuticals Inc Description and Major Businesses
Table 93. Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Progenics Pharmaceuticals Inc Product
Table 95. Progenics Pharmaceuticals Inc Recent Development
Table 96. Strongbridge Biopharma plc Corporation Information
Table 97. Strongbridge Biopharma plc Description and Major Businesses
Table 98. Strongbridge Biopharma plc Somatostatin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Strongbridge Biopharma plc Product
Table 100. Strongbridge Biopharma plc Recent Development
Table 101. Zucara Therapeutics Inc Corporation Information
Table 102. Zucara Therapeutics Inc Description and Major Businesses
Table 103. Zucara Therapeutics Inc Somatostatin Receptor Type 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Zucara Therapeutics Inc Product
Table 105. Zucara Therapeutics Inc Recent Development
Table 106. Global Somatostatin Receptor Type 2 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 107. Global Somatostatin Receptor Type 2 Sales Market Share Forecast by Regions (2021-2026)
Table 108. Global Somatostatin Receptor Type 2 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 109. Global Somatostatin Receptor Type 2 Revenue Market Share Forecast by Regions (2021-2026)
Table 110. North America: Somatostatin Receptor Type 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 111. North America: Somatostatin Receptor Type 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Europe: Somatostatin Receptor Type 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. Europe: Somatostatin Receptor Type 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Asia Pacific: Somatostatin Receptor Type 2 Sales Forecast by Region (2021-2026) (K Pcs)
Table 115. Asia Pacific: Somatostatin Receptor Type 2 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 116. Latin America: Somatostatin Receptor Type 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. Latin America: Somatostatin Receptor Type 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Middle East and Africa: Somatostatin Receptor Type 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Middle East and Africa: Somatostatin Receptor Type 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 121. Key Challenges
Table 122. Market Risks
Table 123. Main Points Interviewed from Key Somatostatin Receptor Type 2 Players
Table 124. Somatostatin Receptor Type 2 Customers List
Table 125. Somatostatin Receptor Type 2 Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Somatostatin Receptor Type 2 Product Picture
Figure 2. Global Somatostatin Receptor Type 2 Sales Market Share by Type in 2020 & 2026
Figure 3. CRN-00808 Product Picture
Figure 4. Lanreotide Acetate Product Picture
Figure 5. PRL-2903 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Somatostatin Receptor Type 2 Sales Market Share by Application in 2020 & 2026
Figure 8. Hormonal Disorder
Figure 9. Oncology
Figure 10. Metabolic Disorder
Figure 11. Others
Figure 12. Somatostatin Receptor Type 2 Report Years Considered
Figure 13. Global Somatostatin Receptor Type 2 Market Size 2015-2026 (US$ Million)
Figure 14. Global Somatostatin Receptor Type 2 Sales 2015-2026 (K Pcs)
Figure 15. Global Somatostatin Receptor Type 2 Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Somatostatin Receptor Type 2 Sales Market Share by Region (2015-2020)
Figure 17. Global Somatostatin Receptor Type 2 Sales Market Share by Region in 2019
Figure 18. Global Somatostatin Receptor Type 2 Revenue Market Share by Region (2015-2020)
Figure 19. Global Somatostatin Receptor Type 2 Revenue Market Share by Region in 2019
Figure 20. Global Somatostatin Receptor Type 2 Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Somatostatin Receptor Type 2 Revenue in 2019
Figure 22. Somatostatin Receptor Type 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Somatostatin Receptor Type 2 Sales Market Share by Type (2015-2020)
Figure 24. Global Somatostatin Receptor Type 2 Sales Market Share by Type in 2019
Figure 25. Global Somatostatin Receptor Type 2 Revenue Market Share by Type (2015-2020)
Figure 26. Global Somatostatin Receptor Type 2 Revenue Market Share by Type in 2019
Figure 27. Global Somatostatin Receptor Type 2 Market Share by Price Range (2015-2020)
Figure 28. Global Somatostatin Receptor Type 2 Sales Market Share by Application (2015-2020)
Figure 29. Global Somatostatin Receptor Type 2 Sales Market Share by Application in 2019
Figure 30. Global Somatostatin Receptor Type 2 Revenue Market Share by Application (2015-2020)
Figure 31. Global Somatostatin Receptor Type 2 Revenue Market Share by Application in 2019
Figure 32. North America Somatostatin Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Somatostatin Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Somatostatin Receptor Type 2 Sales Market Share by Country in 2019
Figure 35. North America Somatostatin Receptor Type 2 Revenue Market Share by Country in 2019
Figure 36. U.S. Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Somatostatin Receptor Type 2 Market Share by Type in 2019
Figure 41. North America Somatostatin Receptor Type 2 Market Share by Application in 2019
Figure 42. Europe Somatostatin Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Somatostatin Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Somatostatin Receptor Type 2 Sales Market Share by Country in 2019
Figure 45. Europe Somatostatin Receptor Type 2 Revenue Market Share by Country in 2019
Figure 46. Germany Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Somatostatin Receptor Type 2 Market Share by Type in 2019
Figure 57. Europe Somatostatin Receptor Type 2 Market Share by Application in 2019
Figure 58. Asia Pacific Somatostatin Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Somatostatin Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Somatostatin Receptor Type 2 Sales Market Share by Region in 2019
Figure 61. Asia Pacific Somatostatin Receptor Type 2 Revenue Market Share by Region in 2019
Figure 62. China Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Somatostatin Receptor Type 2 Market Share by Type in 2019
Figure 85. Asia Pacific Somatostatin Receptor Type 2 Market Share by Application in 2019
Figure 86. Latin America Somatostatin Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Somatostatin Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Somatostatin Receptor Type 2 Sales Market Share by Country in 2019
Figure 89. Latin America Somatostatin Receptor Type 2 Revenue Market Share by Country in 2019
Figure 90. Mexico Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Somatostatin Receptor Type 2 Market Share by Type in 2019
Figure 97. Latin America Somatostatin Receptor Type 2 Market Share by Application in 2019
Figure 98. Middle East and Africa Somatostatin Receptor Type 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Somatostatin Receptor Type 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Somatostatin Receptor Type 2 Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Somatostatin Receptor Type 2 Revenue Market Share by Country in 2019
Figure 102. Turkey Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Somatostatin Receptor Type 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Somatostatin Receptor Type 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Somatostatin Receptor Type 2 Market Share by Type in 2019
Figure 109. Middle East and Africa Somatostatin Receptor Type 2 Market Share by Application in 2019
Figure 110. North America Somatostatin Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Somatostatin Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Somatostatin Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Somatostatin Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Somatostatin Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Somatostatin Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Somatostatin Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Somatostatin Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Somatostatin Receptor Type 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Somatostatin Receptor Type 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

---